Semaglutide Base vs. Salt Forms: Why the Molecule Version in Your Vial Matters

When you pick up a compounded semaglutide prescription, the label lists a dose in milligrams. But milligrams of what, exactly? The answer depends on whether the pharmacy compounded your medication using semaglutide base or semaglutide sodium — and the distinction matters more than most patients realize.

This is not an academic technicality. The molecular form affects dosing calculations, potency comparisons with brand-name products, stability profiles, and even how your pharmacy sources the active ingredient. Understanding the difference helps you ask better questions about what's actually in your vial.

The Chemistry in Plain Language

Semaglutide is a peptide — a chain of amino acids engineered to mimic the GLP-1 hormone your gut produces naturally. Like many pharmaceutical peptides, it can exist in different chemical forms depending on how it's prepared and stored.

Semaglutide Base (Free Base)

This is the "naked" peptide molecule without any attached counterions. When a certificate of analysis (CoA) reports the potency of semaglutide base, it's measuring the active peptide itself. The dosing is straightforward: 1 mg of semaglutide base contains 1 mg of the molecule that binds to your GLP-1 receptors.

Semaglutide Sodium (Salt Form)

Semaglutide sodium is the peptide combined with sodium counterions to form a salt. This salt form can offer improved stability and solubility in certain formulations. However, the sodium adds molecular weight without adding therapeutic activity. A milligram of semaglutide sodium contains slightly less active semaglutide peptide than a milligram of semaglutide base — because part of that weight is sodium.

Why the Dosing Math Isn't Always Apples to Apples

Brand-name Wegovy and Ozempic doses are standardized in terms of the semaglutide peptide itself. When Novo Nordisk says "2.4 mg weekly," they mean 2.4 mg of the active molecule. A compounding pharmacy using semaglutide sodium as its starting material needs to account for the molecular weight difference when calculating the equivalent dose.

The conversion factor is typically in the range of 1.05 to 1.10 — meaning roughly 5-10% more semaglutide sodium by weight is needed to deliver the same amount of active peptide as semaglutide base. This is a standard pharmaceutical calculation, and competent pharmacies apply it routinely. But it's worth confirming that your pharmacy explicitly accounts for the form-to-base conversion in their dosing calculations.

Stability Differences

The salt form of a peptide can behave differently in solution compared to the free base. Semaglutide sodium tends to dissolve more readily in aqueous solutions, which can be an advantage in certain compounding formulations. However, peptide stability in solution depends on multiple factors beyond just the salt form — including pH, preservative system, buffer composition, and storage temperature.

Lyophilized (freeze-dried) preparations may use either form, since the reconstitution process dissolves the peptide fresh each time. Pre-mixed liquid formulations may prefer one form over the other based on the pharmacy's stability testing data.

What the Certificate of Analysis Should Tell You

A properly issued certificate of analysis (CoA) for the API should specify:

• Whether the material is semaglutide base or semaglutide sodium
• The peptide content (purity percentage, typically reported by HPLC)
• The net peptide content — the actual percentage of the powder that is active semaglutide, after accounting for moisture, counterions, and other non-peptide content
• Impurity profiles, including related peptide impurities and degradation products

If your pharmacy provides a CoA (and many compounding-focused providers do upon request), check whether the potency is reported as "semaglutide base equivalent" or "as-is weight." The difference determines whether the labeled dose on your vial reflects the actual active drug you're receiving.

How This Connects to API Sourcing

Compounding pharmacies purchase semaglutide API from FDA-registered chemical suppliers. The form available — base or sodium — depends partly on the supplier's manufacturing process and partly on what the pharmacy's formulation requires. Both forms are legitimate pharmaceutical starting materials when sourced from properly registered facilities with compliant manufacturing documentation.

The important quality markers aren't about which form is "better" — both can produce effective compounded medications. The quality markers are about whether the pharmacy:

• Sources API exclusively from FDA-registered suppliers
• Verifies each lot with an independent certificate of analysis
• Applies correct base-equivalent dosing calculations
• Conducts or commissions potency testing on finished preparations

Providers Who Prioritize Pharmacy Quality

The Practical Takeaway

You do not need to become a pharmaceutical chemist to use a compounded GLP-1 safely. But knowing that "semaglutide" on a label can refer to different molecular forms — and that the distinction affects dose accuracy — makes you a more informed patient. A pharmacy that compounds with precision will welcome these questions. One that cannot explain what's in your vial probably cannot guarantee what's in your vial.